Superio Bio
A pioneering science-driven biotech company advancing a novel class of protein-based biologics with engineered transport, distribution, and durability.
A spinout from the Centre of Excellence Precision Immunotherapy Alliance (PRIMA) and the Laboratory of Adaptive Immunity and Homeostasis at the University of Oslo and Oslo University Hospital, founded in 2025. The technology is based on more than 20 years of academic research from the founding team.
Support
